Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting

van Asseldonk DP, Sanderson J, de Boer NK, Sparrow MP, Lémann M, Ansari A, Almer SH, Florin TH, Gearry RB, Mulder CJ, Mantzaris G, van Bodegraven AA; Thiopurine Task Force Interest Group

(2011), Dig Liver Dis, 43(4), 270-6

Optimizing thiopurine therapy in inflammatory bowel disease

Chevaux JB, Peyrin-Biroulet L, Sparrow MP

(2011), Inflamm Bowel Dis, 17(6), 1428-35

Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts

Roblin X, Oussalah A, Chevaux JB, Sparrow M, Peyrin-Biroulet L

(2011), Inflamm Bowel Dis, 17(12), 2480-7

Thiopurine immunomodulators in ulcerative colitis: moving forward with current evidence

La Nauze RJ, Sparrow MP

(2011), Curr Drug Targets, 12(10), 1406-12

Response to Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

Friedman AB, Sparrow MP

(2011), Inflamm Bowel Dis, 17(12), E161-2

Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia

Moss A, Bourke MJ, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Chen RY, Byth K

(2011), Gastroenterology, 140(7), 1909-18

Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection

Zeuzem S, Asselah T, Angus P, Zarski JP, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse A, Pol S, Bronowicki JP, Roberts S, Arasteh K, Zoulim F, Heim M, Stern JO, Kukolj G, Nehmiz G, Haefner C, Boecher WO

(2011), Gastroenterology, 141(6), 2047-55

Pegylated interferon and ribavirin for the treatment of chronic hepatitis C

Kemp W, Roberts S

(2011), Clin Med Insights Ther, 3, 137-50

Telaprevir for retreatment of HCV infection

Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P, Nevens F, Müllhaupt B, Pockros P, Terg R, Shouval D, van Hoek B, Weiland O, Van Heeswijk R, De Meyer S, Luo D, Boogaerts G, Polo R, Picchio

(2011), N Engl J Med, 364(25), 2417-28

Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1

Sievert W, Dore GJ, McCaughan GW, Yoshihara M, Crawford DH, Cheng W, Weltman M, Rawlinson W, Rizkalla B, Depamphilis JK, Roberts SK; CHARIOT Study Group

(2011), Hepatology, 53(4), 1109-17

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, Desmond PV, Roberts SK, Locarnini S, Bowden S, Angus PW

(2011), Gut, 60(2), 247-54

Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients

Baleriola C, Rawlinson WD, Dore GJ, Chaverot S, Stelzer-Braid S, Yoshihara M, Crawford D, Sievert W, McCaughan G, Weltman M, Cheng W, Rizkalla B, Dubois D, Thommes J, Roberts S

(2011), Antivir Ther, 16(2), 173-80

The prevalence of significant liver fibrosis and cirrhosis in haemophilia patients infected with hepatitis C using FibroScan

Kitson M, Roberts S, Kemp W, Iser D, Walsh M, McCarthy P, Street A, Tran H

(2011), Haemophilia, 17(2), 316-7

Investigation of the safety of irreversible electroporation in humans

Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A

(2011), J Vasc Interv Radiol, 22(5), 611-21

Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection

Berzsenyi MD, Roberts SK, Preiss S, Woollard DJ, Beard MR, Skinner NA, Bowden DS, Visvanathan K

(2011), J Viral Hepatitis, 18(2), 852-60

Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease

Berzsenyi MD, Woollard DJ, McLean CA, Preiss S, Perreau VM, Beard MR, Scott Bowden D, Cowie BC, Li S, Mijch AM, Roberts SK

(2011), J Hepatol, 55(3), 536-44

Urotensin II levels are an important marker for the severity of portal hypertension in children

Pawar R, Kemp W, Roberts S, Krum H, Yandle T, Hardikar W

(2011), J Pediatr Gastroenterol Nutr, 53(1), 88-92

Autoimmune hepatitis: an evolving demography?

Dudley FJ

(2010), J Gastroenterol Hepatol, 25(10), 1591-2

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study

Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F; NormoCAT Study Investigators

(2010), Aliment Pharmacol Ther, 31(8), 834-45

Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation

Lim EJ, Leung C, Pitman A, Stella DL, Brown G, Slattery M, Marion K, Macrae F

(2010), Fam Cancer, 9(4), 555-61

24 25 26 27 28